3154
Z. Li et al. / Bioorg. Med. Chem. 13 (2005) 3149–3155
4-H), 8.50 (d, J = 8 Hz, 1H, 6-H). HRMS (ESI): calcd
10, 20, 40 lM, one contained calf thymus DNA
50 lM, the other contained no DNA but had the
same concentration of chemical as control. All the
above solution was shaken for 3 days at 25 ꢁC in
the dark. Fluorescence wavelength and intensity
area of samples were measured.
for C22H22N3OS (M+H)+: 376.1484. Found: 376.1475.
IR (KBr): 3285, 2921, 2850, 1635, 1536, 761 cmꢀ1
.
4.2.5. N-(2-(Dimethylamino)ethyl)-2-(4-methoxyphenyl)
naphtha[2,1-d]thiazole-5-carboxamide (B2). Prepared in
a similar manner as that in B1, 4-methoxybenzaldehyde
was used here instead of benzaldehyde and separated on
silica gel chromatography (CH2Cl2/MeOH, 4:1, v/v).
(b) Solution of B3 (0.25 mL), in DMSO (10ꢀ3 M)
mixed with 20 mM Tris–HCl (pH 7.5) to 5 mL.
Then, one group of samples were prepared in the
concentration of chemical at 50 lM, one did not
contain calf thymus DNA as control, the others
contained DNA with the concentration of 50, 100,
200 lM, respectively. All the above solution was
shaken for 3 days at 25 ꢁC in the dark. Absorption
spectra of samples were measured.
1
Mp: 194–195 ꢁC. H NMR (CDCl3-d6) d (ppm): 2.92
(s, 6H, NCH3), 3.44 (s, 2H, NCH2), 3.86 (s, 3H,
OCH3), 3.98 (s, 2H, CONHCH2), 6.92 (d, J = 8.8 Hz,
2H, 30-H, 50-H), 7.46 (m, J1 = 7.6 Hz, J2 = 8.8 Hz,
J3 = 8.8 Hz, J4 = 6.4 Hz, 2H, 7-H, 8-H), 7.82 (d,
J = 7.6 Hz, 6-H), 7.89 (d, J = 8.4 Hz, 2H, 20-H, 60-H),
8.30 (s, 1H, 4-H), 8.33 (d, J = 8 Hz, 1H, 9-H), 8.57 (s,
1H, CONH). HRMS (ESI): calcd for C23H24N3O2S
(M+H)+: 406.1545. Found: 406.1554. IR (KBr): 3285,
4.2.10. Cytotoxic activity in vitro. The prepared com-
pounds have been submitted to Shanghai Institute of
Materia Medica for testing their cytotoxicities in vitro.
2921, 2850, 1635, 1606, 827 cmꢀ1
.
4.2.6. N-(2-(Dimethylamino)ethyl)-2-(3-nitrophenyl) naph-
tho[2,1-d]thiazole-5-carboxamide (B3). Prepared in a sim-
ilar manner as that in B1, 3-nitrobenzaldehyde was used
here instead of benzaldehyde and separated on silica gel
chromatography (CH2Cl2/MeOH, 3:1, v/v). Mp: 225.1–
226 ꢁC. 1H NMR (DMSO-d6) d (ppm): 2.50 (s, H,
NCH3), 2.58 (s, 2H, NCH2), 3.50 (s, 2H, CONHCH2),
7.69 (t, J1 = 8.1 Hz, J2 = 7.2 Hz, 1H, 8-H), 7.753 (t,
J1 = 7.8 Hz, J2 = 7.2 Hz, 1H, 7-H), 7.90 (t, J1 = 8.1 Hz,
J2 = 7.2 Hz, 1H, 50-H), 8.22 (d, J = 6 Hz, 2H, 20-H, 9-
H), 8.39 (d, J = 8.2 Hz, 2H, 40-H, 60-H), 8.54 (d,
J = 7.9 Hz 1H, 6-H), 8.86 (s, 1H, 4-H), HRMS (ESI):
calcd for C22H21N4O3S (M+H)+): 421.1334. Found:
421.1332. IR (KBr): 3272, 2947, 2859, 1639, 1532,
4.2.11. Photocleavage of supercoiled pBR322 DNA. Two
hundred and fifty nanograms of pBR322 DNA (form I),
1 lL solution of chemical in organic solvent and 20 mM
Tris–HCl (pH 7.5) were mixed to 10 lL, then irradiated
for 3 h with light (360 nm) using lampplaced at 20 cm
from sample. The samples were analyzed by gel electro-
phoresis in 1% agarose gel which was stained with ethi-
dium bromide. Supercoiled DNA runs at position I,
nicked DNA at position II.
Acknowledgments
Financial support by the National Key Project for Basic
Research (2003CB114400) and under the auspices of
National Natural Science Foundation of China is
greatly appreciated.
1344, 760 cmꢀ1
.
4.2.7. N-(2-(Dimethylamino)ethyl)-2-p-tolylnaphtho[2,1-d]-
thiazole-5-carboxamide (B4). Prepared in a similar
manner as that in B1, 4-methylbenzaldehyde was used
here instead of benzaldehyde and separated on silica
gel chromatography (CH2Cl2/MeOH, 6:1, v/v). Mp:
References and notes
1
1. (a) Bran˜a, M. F.; Cacho, M.; Gradillas, A.; Pascual-Teresa,
B.; Ramos, A. Curr. Pharm. Des. 2001, 7, 1745; (b) Bran˜a,
M. F.; Ramos, A. Curr. Med. Chem.: Anti-cancer Agents
2001, 1, 237; (c) Sami, S. M.; Dorr, R. T.; Alberts, D. S.;
Remers, W. A. J. Med. Chem. 1993, 36, 765; (d) Sami, S.
M.; Dorr, R. T.; Alberts, D. S. J. Med. Chem. 2000, 43,
3067; (e) Bran˜a, M. F.; Cacho, M.; Garcia, M. A. J. Med.
Chem. 2002, 45, 5813; (f) Bran˜a, M. F.; Cacho, M.; Garcia,
M. A. J. Med. Chem. 2004, 47, 1391.
2. (a) Qian, X.; Yao, W. Tetrahedron Lett. 2001, 42, 6175; (b)
Qian, X.; Mao, P.; Yao, W.; Guo, X. Tetrahedron Lett.
2002, 43, 2995; (c) Yao, W.; Qian, X.; Hu, Q. Tetrahedron
Lett. 2000, 41, 7711; (d) Li, Y.; Xu, Y.; Qian, X. Bioorg.
Med. Chem. Lett. 2003, 13, 3513; (e) Qian, X.; Li, Y.; Xu,
Y. Bioorg. Med. Chem. Lett. 2004, 14, 2665; (f) Li, Y.; Xu,
Y.; Qian, X. Tetrahedron Lett. 2004, 45, 1247; (g) Xu, Y.;
Qian, X. Bioorg. Med. Chem. 2003, 11, 5427.
3. (a) Satio, I.; Takayama, M.; Sakurai, T. J. Am. Chem. Soc.
1994, 116, 2653; (b) Satio, I.; Takayama, M. J. Am. Chem.
Soc. 1995, 117, 5590; (c) Satio, I.; Takayama, M.; Sugiy-
ama, H.; Nakatani, K. J. Am. Chem. Soc. 1995, 117, 6406.
4. (a) Leuck, B. G.; Perkins, R. P.; Whitmore, F. C. J. Am.
Chem. Soc. 1929, 51, 1831; (b) Whitmore, F. C.; Fox, A. L.
J. Am. Chem. Soc. 1929, 51, 3363; (c) Bailey, R. J.;
189–190 ꢁC. H NMR (CDCl3-d6) d (ppm): 2.39 (s, H,
NCH3), 2.43 (s, 3H, CH3), 2.73 (t, J = 5.6 Hz, 2H,
NCH2), 3.70 (d, J = 5.6 Hz, 2H, CONHCH2), 7.16 (s,
1H, CONH), 7.30 (d, J = 8 Hz, 2H, 30-H, 50-H), 7.58
(m, J1 = 5.6 Hz, J2 = 8.4 Hz, J3 = 8 Hz, J4 = 7.2 Hz,
2H, 7-H, 8-H), 7.98 (d, J = 8 Hz, 3H, 1-H, 20-H, 60-H),
8.24 (s, 1H, 4-H), 8.459 (d, J = 8 Hz, 1H, 6-H). HRMS
(ESI): calcd for C23H24N3OS (M+H+): 390.1640.
Found: 390.1618. IR (KBr): 3273, 2922, 2852, 1634,
1537, 820 cmꢀ1
.
4.2.8. 2-Phenyl thiazonaphthalic anhydride (7). Prepared
in a similar manner as that in 2-phenylnaphtho[2,1-d]-
thiazole-5-carboxylic acid 6, 4-bromo-3-nitro-1,8-
naphthalic anhydride was used here instead of
4-bromo-3-nitro-1-naphthoic acid 3.
4.2.9. Intercalation studies of compounds to CT-DNA
(a) Solution of compound B1, B2, B4 (0.1 mL) in
DMSO (10ꢀ3–10ꢀ4 M) mixed with 20 mM Tris–
HCl (pH 7.5) to 5 mL. Then, two groups of samples
were prepared in the concentration of chemical at 5,